5 Best Income Stocks To Buy Right Now

4. AbbVie Inc. (NYSE:ABBV)

Dividend Yield: 4.83%

Number of Hedge Fund Holders: 82

Number of Years of Consistent Dividend Growth: 49

AbbVie Inc. (NYSE:ABBV) is an American biopharmaceutical company that was established in 2013. AbbVie Inc. (NYSE:ABBV) is engaged in medical research and development, and produces drugs for diseases to help patients with oncology, immunology, and virology related health issues, among others. AbbVie Inc. (NYSE:ABBV) is one of the best income stocks according to our research. 

At the end of June, 82 hedge funds reported owning stakes in AbbVie Inc. (NYSE:ABBV), up from 72 in the previous quarter. 

On October 29, AbbVie Inc. (NYSE:ABBV) announced earnings for Q3. The EPS was $3.33, exceeding estimated EPS by $0.11. The revenue for AbbVie Inc. (NYSE:ABBV) was $14.34 billion, beating estimates by $43.38 million. 

Morgan Stanley analyst David Risinger kept an Overweight rating on AbbVie Inc. (NYSE:ABBV), raising the price target from $116 to $124 on November 1, owing to a strong Q3 performance.